arginyl-threonyl-prolyl-prolyl-prolyl-seryl-glycine: synthetic heptapeptide substrates for protein kinase; SP-7 is D-Arg
ID Source | ID |
---|---|
PubMed CID | 146985 |
MeSH ID | M0138124 |
Synonym |
---|
sp 6 |
2-[[(2s)-2-[[(2s)-1-[(2s)-1-[(2s)-1-[(2s,3r)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]acetic acid |
n-(n-(1-(1-(1-(n-l-arginyl-l-threonyl)-l-prolyl)-l-prolyl)-l-prolyl)-l-seryl)glycine |
arginyl-threonyl-prolyl-prolyl-prolyl-seryl-glycine |
101020-48-8 |
sp 7 |
arg-thr-pro-pro-pro-ser-gly |
glycine, n-(n-(1-(1-(1-(n-l-arginyl-l-threonyl)-l-prolyl)-l-prolyl)-l-prolyl)-l-seryl)- |
DTXSID50143678 |
Excerpt | Relevance | Reference |
---|---|---|
" Intravenous injection of SP-6 in rabbits at the dosage of 14." | ( [Synthesis and biological activity of an analogue of active fragment (SP-6) of substance P]. Hu, XY; Li, RD; Wang, ZY; Yang, GL, 1994) | 0.29 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.92) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 3 (42.86%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (57.14%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |